| Profile | GDS4284 / 211528_x_at |
| Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM687644 | Patient 401 control | 38311.9 | 99 |
| GSM687648 | Patient 402 control | 45958.8 | 99 |
| GSM687653 | Patient 403 control | 48298 | 99 |
| GSM687658 | Patient 404 control | 43712.7 | 99 |
| GSM687663 | Patient 411 control | 58069.9 | 99 |
| GSM687668 | Patient 422 control | 40791 | 99 |
| GSM687673 | Patient 424 control | 46361 | 99 |
| GSM687678 | Patient 425 control | 50917.2 | 99 |
| GSM687683 | Patient 427 control | 39132 | 99 |
| GSM687688 | Patient 428 control | 54493.3 | 99 |
| GSM687695 | Patient 441 control | 61055 | 99 |
| GSM687699 | Patient 443 control | 48577.8 | 99 |
| GSM687704 | Patient 444 control | 40692.3 | 99 |
| GSM687707 | Patient 448 control | 33651.5 | 99 |
| GSM687712 | Patient 449 control | 31326.3 | 99 |
| GSM687719 | Patient 450 control | 53386.4 | 99 |
| GSM687724 | Patient 451 control | 41262 | 99 |
| GSM687728 | Patient 452 control | 51699.1 | 99 |
| GSM687646 | Patient 401 treated 24h | 39461.9 | 99 |
| GSM687649 | Patient 402 treated 24h | 49806.5 | 99 |
| GSM687665 | Patient 411 treated 24h | 45505.7 | 99 |
| GSM687651 | Patient 402 treated 4 weeks | 55471.5 | 99 |
| GSM687667 | Patient 411 treated 4 weeks | 40504.1 | 99 |
| GSM687670 | Patient 422 treated 24h | 39104.4 | 99 |
| GSM687671 | Patient 422 treated 4 weeks | 41196.3 | 99 |
| GSM687654 | Patient 403 treated 24h | 45509.8 | 99 |
| GSM687675 | Patient 424 treated 24h | 52585.8 | 99 |
| GSM687685 | Patient 427 treated 24h | 63406.1 | 99 |
| GSM687656 | Patient 403 treated 4 weeks | 47766.5 | 99 |
| GSM687677 | Patient 424 treated 4 weeks | 48432.9 | 99 |
| GSM687687 | Patient 427 treated 4 weeks | 46217.3 | 99 |
| GSM687692 | Patient 428 treated 4h | 37313.2 | 99 |
| GSM687716 | Patient 449 treated 4h | 40154.3 | 99 |
| GSM687722 | Patient 450 treated 4h | 24817.3 | 99 |
| GSM687680 | Patient 425 treated 24h | 33105.4 | 99 |
| GSM687690 | Patient 428 treated 24h | 31611.8 | 99 |
| GSM687700 | Patient 443 treated 24h | 30944 | 99 |
| GSM687705 | Patient 444 treated 24h | 37604.8 | 99 |
| GSM687714 | Patient 449 treated 24h | 33621.5 | 99 |
| GSM687721 | Patient 450 treated 24h | 40000.5 | 99 |
| GSM687682 | Patient 425 treated 4 weeks | 52269.6 | 99 |
| GSM687694 | Patient 428 treated 4 weeks | 40544.1 | 99 |
| GSM687702 | Patient 443 treated 4 weeks | 39896.9 | 99 |
| GSM687718 | Patient 449 treated 4 weeks | 43958 | 99 |
| GSM687723 | Patient 450 treated 4 weeks | 40228.8 | 99 |
| GSM687661 | Patient 404 treated 4h | 36600.1 | 99 |
| GSM687710 | Patient 448 treated 4h | 32125.7 | 99 |
| GSM687726 | Patient 451 treated 4h | 45879.2 | 99 |
| GSM687730 | Patient 452 treated 4h | 11771.2 | 98 |
| GSM687660 | Patient 404 treated 24h | 32045.6 | 99 |
| GSM687697 | Patient 441 treated 24h | 75922.8 | 100 |
| GSM687709 | Patient 448 treated 24h | 30357.2 | 99 |
| GSM687725 | Patient 451 treated 24h | 37359.3 | 99 |
| GSM687729 | Patient 452 treated 24h | 62759.6 | 99 |
| GSM687727 | Patient 451 treated 4 weeks | 42965.4 | 99 |
| GSM687731 | Patient 452 treated 4 weeks | 48326.6 | 99 |